On December 8, 2020 Isofol reported that an abstract, including arfolitixorin in the ISO-CC-005 study, has been accepted to be presented at ASCO (Free ASCO Whitepaper) GI in January 2021 (Press release, Isofol Medical, DEC 8, 2020, View Source [SID1234572400]). The upcoming congress American Society of Clinical Oncology (ASCO) (Free ASCO Whitepaper) Gastrointestinal (ASCO GI), taking place in January 15-17, 2021, will be a virtual exhibition. In connection to this Isofol, together with QuartzBio, The Sahlgrenska Academy of Gothenburg and Sahlgrenska University, will present a poster including arfolitixorin from the ISO-CC-005 study.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!